{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:26:41Z","timestamp":1761391601578},"reference-count":18,"publisher":"BMJ","issue":"Suppl 4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,9,20]]},"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>Many countries in Africa have weak surveillance systems for data collection of sexually transmitted infections, and hardly any programmes for gonococcal antimicrobial susceptibility assessment. The widespread adoption of the syndromic approach to the diagnosis and management of sexually transmitted infections has also meant that the collection of a genital specimen for laboratory analysis is no longer routinely done when patients present with genital complaints, and clinical staff and laboratory technicians have lost the skill to collect genital specimens and processing them for culture and antimicrobial susceptibility testing. Following reports of gonococcal antimicrobial resistance to quinolones, WHO urged countries to monitor gonococcal antimicrobial resistance in a more systematic and regular manner. Although the response in Africa has been slow to take off, a number of studies have been conducted in a few countries and plans for implementation are in place in others. However, the number of isolates studied has been small in nearly all the countries except one, and the barriers to scaling up gonococcal antimicrobial resistance surveys seem overwhelming. In spite of the studies being few and of small sample sizes, enough information can be discerned to indicate that quinolones can no longer be a medicine of choice for the treatment of gonorrhoea in Africa and the threat of antimicrobial resistance developing in<jats:italic>Neisseria gonorrhoeae<\/jats:italic>to third-generation cephalosporins is real and imminent.<\/jats:p>","DOI":"10.1136\/sextrans-2012-050907","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T14:33:46Z","timestamp":1384526026000},"page":"iv11-iv15","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Gonococcal antimicrobial resistance: perspectives from the African region"],"prefix":"10.1136","volume":"89","author":[{"given":"Francis J","family":"Ndowa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Machiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hortense","family":"Faye-Kette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Christine","family":"Fonkoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"2024051410035942000_89.Suppl_4.iv11.1","unstructured":"World Health Organization. WHO Global incidence and prevalence of selected curable sexually transmitted infections\u20142008. Geneva: World Health Organization, 2012. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/2008_STI_estimates.pdf"},{"key":"2024051410035942000_89.Suppl_4.iv11.2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.029611"},{"key":"2024051410035942000_89.Suppl_4.iv11.3","unstructured":"Antimicrobial Survey City of Harare\u2014presentation at the 2012 Zimbabwe STI Update (Ms. Machiha). http:\/\/www.stdpreventiononline.org\/index.php\/resources\/resources\/ (accessed 21 Mar 2013)."},{"key":"2024051410035942000_89.Suppl_4.iv11.4","first-page":"199","article-title":"Detection of multidrug-resistant gonorrhoea in the Gauteng province","volume":"27","author":"Lewis","year":"2012","journal-title":"South Afr J Epidemiol Infect"},{"key":"2024051410035942000_89.Suppl_4.iv11.5","doi-asserted-by":"crossref","first-page":"pii = 19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"2024051410035942000_89.Suppl_4.iv11.6","doi-asserted-by":"crossref","first-page":"pii = 19792","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"2024051410035942000_89.Suppl_4.iv11.7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq289"},{"key":"2024051410035942000_89.Suppl_4.iv11.8","unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: World Health Organization, 2012. ISBN: 978 92 4 150350 1."},{"key":"2024051410035942000_89.Suppl_4.iv11.9","first-page":"818","article-title":"Eradicating chancroid","volume":"79","author":"Steen","year":"2001","journal-title":"Bull World Health Organ"},{"key":"2024051410035942000_89.Suppl_4.iv11.10","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200001000-00001"},{"key":"2024051410035942000_89.Suppl_4.iv11.11","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31818318d8"},{"key":"2024051410035942000_89.Suppl_4.iv11.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000636"},{"key":"2024051410035942000_89.Suppl_4.iv11.13","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.048777"},{"key":"2024051410035942000_89.Suppl_4.iv11.14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00155-11"},{"key":"2024051410035942000_89.Suppl_4.iv11.15","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181bf575c"},{"key":"2024051410035942000_89.Suppl_4.iv11.16","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181982e3c"},{"key":"2024051410035942000_89.Suppl_4.iv11.17","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050108.10"},{"key":"2024051410035942000_89.Suppl_4.iv11.18","unstructured":"Gonococcal antimicrobial resistance surveillance. National Institute For Communicable Diseases Annual Review 2011\u20132012;p21: http:\/\/www.nhls.ac.za\/assets\/files\/NICD%20Annual%20Review(1).pdf (accessed 7 Apr 2013)."}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2012-050907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:04:40Z","timestamp":1715706280000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2012-050907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":18,"journal-issue":{"issue":"Suppl 4","published-online":{"date-parts":[[2013,11,15]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/sextrans-2012-050907"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2012-050907","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}